IDEXX Laboratories, Inc. (IDXX)
629.35
+12.15
(+1.97%)
USD |
NASDAQ |
Feb 13, 16:00
629.23
-0.12
(-0.02%)
After-Hours: 20:00
IDEXX Laboratories Cash from Investing (Quarterly) : -28.13M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Intuitive Surgical, Inc. | -209.40M |
| Boston Scientific Corp. | -- |
| Revvity, Inc. | -20.45M |
| Merck & Co., Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 355.76M |
| Cash from Financing (Quarterly) | -355.70M |
| Free Cash Flow | 1.044B |
| Free Cash Flow Per Share (Quarterly) | 4.055 |
| Free Cash Flow to Equity (Quarterly) | 591.45M |
| Free Cash Flow to Firm (Quarterly) | 333.30M |
| Free Cash Flow Yield | 2.05% |